FR13C0008I2 - Derives de phosphonocephem, leur procede de preparation et leur utilisation - Google Patents
Derives de phosphonocephem, leur procede de preparation et leur utilisationInfo
- Publication number
- FR13C0008I2 FR13C0008I2 FR13C0008C FR13C0008C FR13C0008I2 FR 13C0008 I2 FR13C0008 I2 FR 13C0008I2 FR 13C0008 C FR13C0008 C FR 13C0008C FR 13C0008 C FR13C0008 C FR 13C0008C FR 13C0008 I2 FR13C0008 I2 FR 13C0008I2
- Authority
- FR
- France
- Prior art keywords
- preparation process
- phosphonocephem
- derivatives
- phosphonocephem derivatives
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- JKKCZQKHMGGMQT-LWOQYNTDSA-N P(=O)(O)(O)C1S[C@H]2N(C=C1)C(C2)=O Chemical class P(=O)(O)(O)C1S[C@H]2N(C=C1)C(C2)=O JKKCZQKHMGGMQT-LWOQYNTDSA-N 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65613—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. cephalosporins and analogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP35149997 | 1997-12-19 | ||
| PCT/JP1998/005709 WO1999032497A1 (fr) | 1997-12-19 | 1998-12-17 | Derives de phosphonocephem, leur procede de preparation et leur utilisation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR13C0008I1 FR13C0008I1 (enrdf_load_stackoverflow) | 2013-03-22 |
| FR13C0008I2 true FR13C0008I2 (fr) | 2013-08-16 |
Family
ID=18417716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR13C0008C Active FR13C0008I2 (fr) | 1997-12-19 | 2013-02-06 | Derives de phosphonocephem, leur procede de preparation et leur utilisation |
Country Status (19)
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1310502B1 (en) * | 2000-08-10 | 2009-05-20 | Takeda Pharmaceutical Company Limited | Phosphonocephem compound |
| US20070249577A1 (en) * | 2005-05-10 | 2007-10-25 | Hopkins Scott J | Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures |
| US20070238719A1 (en) * | 2005-05-10 | 2007-10-11 | Hopkins Scott J | Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures |
| US20070238720A1 (en) * | 2005-05-10 | 2007-10-11 | Hopkins Scott J | Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures |
| CN101357929B (zh) * | 2007-06-22 | 2010-12-15 | 山东轩竹医药科技有限公司 | 含有巯基噻二唑的头孢菌素衍生物 |
| US20090082326A1 (en) * | 2007-09-21 | 2009-03-26 | Forest Laboratories Holdings Limited | Soluble dosage forms containing cephem derivatives suitable for parenteral administration |
| CN103212076A (zh) * | 2008-08-28 | 2013-07-24 | 阿斯利康(瑞典)有限公司 | 包含头孢洛林的组合物和治疗方法 |
| CA2753387C (en) * | 2009-02-23 | 2017-01-24 | Forest Laboratories Holdings Limited | Novel cephem compounds useful for the treatment of bacterial infections |
| AU2010295269B2 (en) | 2009-09-21 | 2014-06-05 | Pfizer Anti-Infectives Ab | Compositions and methods for treating bacterial infections using ceftaroline |
| FR2951171A1 (fr) | 2009-10-09 | 2011-04-15 | Novexel | Nouveau sel de sodium d'un compose azabicyclique sous forme enantiomere cristallisee et nouvelles formes polymorphes et pseudopolymorphes ainsi que leur preparation |
| KR102143660B1 (ko) | 2011-06-17 | 2020-08-11 | 화이자 안티-인펙티브스 에이비 | 트랜스-7-옥소-6-(술포옥시)-1,6-디아자비시클로[3,2,1]옥탄-2-카르복스아미드 및 그의 염을 포함하는 헤테로시클릭 화합물의 제조 방법 |
| WO2013084171A1 (en) | 2011-12-07 | 2013-06-13 | Ranbaxy Laboratories Limited | Process for preparing ceftaroline salts or hydrates thereof |
| JP6301346B2 (ja) * | 2012-10-19 | 2018-03-28 | サンド・アクチエンゲゼルシヤフト | セフタロリンフォサミルの新規製造方法 |
| CN102977124B (zh) * | 2012-12-13 | 2014-11-26 | 山东诚创医药技术开发有限公司 | 7β-[(苯乙酰)氨基]-3-[4-(1-甲基-4-吡啶鎓)-2-噻唑硫基]-3-头孢烯-4-羧酸二苯甲基酯的制备方法 |
| US9534004B2 (en) | 2012-12-20 | 2017-01-03 | Sandoz Ag | Crystalline forms of ceftaroline fosamil |
| JP6671303B2 (ja) | 2014-02-21 | 2020-03-25 | ミクウルク ファーマシューティカルズ，インコーポレイテッド | 治療的投与のための水溶性ｏ−カルボニルホスホルアミダートプロドラッグ |
| CN106565784B (zh) * | 2016-10-31 | 2019-02-26 | 瑞阳制药有限公司 | 头孢洛林酯二钠盐的纯化方法 |
| CN110872322B (zh) * | 2018-08-29 | 2022-08-02 | 上海博志研新药物技术有限公司 | 乙酸头孢罗膦一水合物及其中间体的制备方法 |
| CN113072567B (zh) * | 2021-03-26 | 2022-10-14 | 海南海灵化学制药有限公司 | 一种拉氧头孢钠合成工艺 |
| CN113214323A (zh) * | 2021-04-30 | 2021-08-06 | 瑞阳制药股份有限公司 | 分段式头孢罗膦高效稳定析晶方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5941999B2 (ja) | 1975-07-24 | 1984-10-11 | 武田薬品工業株式会社 | セフエムまたはベナム化合物の製造法 |
| JPS5511600A (en) * | 1978-07-10 | 1980-01-26 | Fujisawa Pharmaceut Co Ltd | Cephem compound, its salt, their preparation and remedy and prophylactic for microbism containing mainly the same |
| US4268509A (en) | 1978-07-10 | 1981-05-19 | Fujisawa Pharmaceutical Co., Ltd. | New cephem compounds and processes for preparation thereof |
| FR2511372A1 (fr) | 1981-08-17 | 1983-02-18 | Rhone Poulenc Sante | Nouveaux derives de la cephalosporine et leur preparation |
| US4563449A (en) * | 1982-07-19 | 1986-01-07 | Fujisawa Pharmaceutical Co., Ltd. | Cephem compounds |
| JPS5931791A (ja) * | 1982-07-19 | 1984-02-20 | Fujisawa Pharmaceut Co Ltd | 新規セフエム化合物およびその製造法、並びに細菌感染症予防・治療剤 |
| JPS62238291A (ja) * | 1986-04-10 | 1987-10-19 | Fujisawa Pharmaceut Co Ltd | セフエム化合物および医薬として許容されるその塩 |
| US4978663A (en) * | 1989-08-16 | 1990-12-18 | Hoechst-Roussel Pharmaceuticals Inc. | 5-(1-aminocyclohexyl)-2(1H)-pyridinone compounds which have pharmaceutical utility |
| JP3514495B2 (ja) | 1992-10-02 | 2004-03-31 | エーザイ株式会社 | ハロゲン化アミノチアジアゾリル酢酸誘導体の製造法 |
| JP3927262B2 (ja) * | 1995-07-19 | 2007-06-06 | 武田薬品工業株式会社 | セフェム化合物、その製造法および抗菌組成物 |
| JPH10265488A (ja) * | 1997-03-27 | 1998-10-06 | Takeda Chem Ind Ltd | ホスフォノセフェム誘導体 |
-
1998
- 1998-12-02 TW TW087119933A patent/TW473479B/zh not_active IP Right Cessation
- 1998-12-17 EP EP09158866A patent/EP2080765A1/en not_active Withdrawn
- 1998-12-17 KR KR10-2000-7006796A patent/KR100384047B1/ko not_active Expired - Lifetime
- 1998-12-17 JP JP35888798A patent/JP3467418B2/ja not_active Expired - Lifetime
- 1998-12-17 DE DE69840796T patent/DE69840796D1/de not_active Expired - Lifetime
- 1998-12-17 EP EP98961385A patent/EP1043327B1/en not_active Expired - Lifetime
- 1998-12-17 PT PT98961385T patent/PT1043327E/pt unknown
- 1998-12-17 US US09/555,949 patent/US6417175B1/en not_active Expired - Lifetime
- 1998-12-17 CN CNB988122944A patent/CN1194980C/zh not_active Expired - Lifetime
- 1998-12-17 ES ES98961385T patent/ES2325139T3/es not_active Expired - Lifetime
- 1998-12-17 CN CN2005100079635A patent/CN1679595B/zh not_active Expired - Lifetime
- 1998-12-17 WO PCT/JP1998/005709 patent/WO1999032497A1/ja active IP Right Grant
- 1998-12-17 CA CA002314564A patent/CA2314564C/en not_active Expired - Lifetime
- 1998-12-17 AU AU16832/99A patent/AU1683299A/en not_active Abandoned
- 1998-12-17 AT AT98961385T patent/ATE430155T1/de active
- 1998-12-17 DK DK98961385T patent/DK1043327T3/da active
-
2000
- 2000-07-04 JP JP2000206824A patent/JP2001048893A/ja active Pending
-
2009
- 2009-01-16 JP JP2009007750A patent/JP2009114202A/ja not_active Abandoned
- 2009-07-29 CY CY20091100809T patent/CY1109276T1/el unknown
-
2013
- 2013-01-07 CY CY2013003C patent/CY2013003I2/el unknown
- 2013-01-08 BE BE2013C004C patent/BE2013C004I2/fr unknown
- 2013-01-11 NL NL300568C patent/NL300568I2/nl unknown
- 2013-01-16 LU LU92134C patent/LU92134I2/fr unknown
- 2013-02-06 FR FR13C0008C patent/FR13C0008I2/fr active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR13C0008I2 (fr) | Derives de phosphonocephem, leur procede de preparation et leur utilisation | |
| FR2784107B1 (fr) | Microfibrilles de cellulose a surface modifiee, leur procede de preparation, et leur utilisation | |
| EP0710667A3 (de) | Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung | |
| FR2732680B1 (fr) | Composes de type ceramides, leur procede de preparation et leur utilisation | |
| PT901474E (pt) | Derivados de aril-pirimidina. | |
| EE03482B1 (et) | Kinasoliiniderivaadid, nende valmistamismeetod ja kasutamine | |
| FR2660556B1 (fr) | Microspheres, leur procede de preparation et leur utilisation. | |
| EE04721B1 (et) | Fenüülksantiini derivaadid, nende valmistamismeetodid ja kasutamine | |
| EE9800265A (et) | Erütromütsiini derivaadid, nende valmistamismeetod ja kasutamine ravimitena | |
| EE9800302A (et) | Arüülglütsiinamiidi derivaadid, nende valmistamismeetod ja kasutamine ning farmatseutiline preparaat | |
| NO975977L (no) | Substituerte purinderivater, fremgangsmÕter for fremstilling og anvendelse derav | |
| PT922050E (pt) | Derivados de 3-descladinose-2,3-anidroeritromicina | |
| NO960499L (no) | Antineurodegenerativt virksomme 10-aminoalifatyldibenz[b,fÅoksepiner | |
| FR2680506B1 (fr) | Procede de preparation de derives de la beta-phenylisoserine et leur utilisation. | |
| EP0978524A4 (en) | FLUOROPOLYMERS, METHOD FOR THEIR PRODUCTION AND THEIR USE | |
| EP1023250A4 (en) | METHOD FOR PRODUCING 2,6-DIALKYLNAPHTHALINE | |
| EP0890599A4 (en) | POLYORGANOSILOXANES AND METHOD FOR THE PRODUCTION THEREOF | |
| FI954946L (fi) | Kinoksaliinit, menetelmä niiden valmistamiseksi ja niiden käyttö | |
| PT931087E (pt) | Novos derivados de piranosido | |
| MA24470A1 (fr) | Procede | |
| GR3035834T3 (en) | Benzoxazindione derivatives, process for their preparation and their use | |
| MA26590A1 (fr) | Derives de thiazole, leur procede de preparation et leur utilisation. | |
| FR2765874B1 (fr) | Derives de 6-pyrrolidin-2-ylpyrindines, leur preparation et leur application en therapeutique | |
| ZA9810403B (en) | New epothilon derivatives, process for their preparation and their pharmaceutical use. | |
| BR9701404A (pt) | Derivados de 1,25-diidróxi-16,22,23-trisdeidro-colecal-ciferol |